Journal articlePharmacoepidemiol Drug Saf2018
Use of proton pump inhibitors and risk of pancreatic cancer.
- Journal
- Pharmacoepidemiol Drug Saf
- Published
- 20 June 2018
- Citations
- 17
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Purpose Preclinical studies have suggested that proton pump inhibitors (PPIs) may increase pancreatic cancer risk; however, epidemiological studies are few, with conflicting results. This spurred us to evaluate whether PPI use is associated with an increased risk of pancreatic cancer in a large population-based study. … Excerpt only: this text is the publisher’s. Read it in full at the source.